The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H22 Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis
Ciji-Hua’ai-Baosheng II Formula (CHB-II-F) is a traditional Chinese medical formula that has been shown in clinical practice to relieve side effects of chemotherapy and improve quality of life for cancer patients. In order to understand the mechanism of its protective effects on chemotherapy, mice w...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.01539/full |
id |
doaj-3fe77e8aa7c64e38ab0155edfc6fab2e |
---|---|
record_format |
Article |
spelling |
doaj-3fe77e8aa7c64e38ab0155edfc6fab2e2020-11-25T02:42:01ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-01-01910.3389/fphar.2018.01539419824The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H22 Hepatocellular Carcinoma Mouse Model by Promoting Tumor ApoptosisBiqian Fu0Shengyan Xi1Shengyan Xi2Shengyan Xi3Yanhui Wang4Yanhui Wang5Yanhui Wang6Xiangyang Zhai7Yanan Wang8Yuewen Gong9Yangxinzi Xu10Jiaqi Yang11Yingkun Qiu12Jing Wang13Dawei Lu14Shuqiong Huang15Department of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen, ChinaDepartment of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen, ChinaCancer Research Center, Xiamen University, Xiamen, ChinaDepartment of Traditional Chinese Medicine, Xiang’an Hospital of Xiamen University, Xiamen, ChinaDepartment of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen, ChinaCancer Research Center, Xiamen University, Xiamen, ChinaDepartment of Traditional Chinese Medicine, Xiang’an Hospital of Xiamen University, Xiamen, ChinaDepartment of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen, ChinaDepartment of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen, ChinaCollege of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, CanadaDepartment of Physiology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, CanadaCollege of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, CanadaSchool of Pharmaceutical Sciences, Xiamen University, Xiamen, ChinaSchool of Pharmaceutical Sciences, Xiamen University, Xiamen, ChinaDepartment of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen, ChinaDepartment of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen, ChinaCiji-Hua’ai-Baosheng II Formula (CHB-II-F) is a traditional Chinese medical formula that has been shown in clinical practice to relieve side effects of chemotherapy and improve quality of life for cancer patients. In order to understand the mechanism of its protective effects on chemotherapy, mice with transplanted H22 hepatocellular carcinoma were employed in this study. Ninety-two mice were injected subcutaneously with H22 HCC cell suspension into the right anterior armpit. After mice were treated with 5-fluorine pyrimidine (5-FU), they were divided into six groups as untreated group, 5-FU group, 5-FU plus Yangzheng Xiaoji Capsule group and three groups of 5-FU plus different concentrations of CHB-II-F. Twenty mice were euthanized after 7 days of treatment in untreated and medium concentration of CHB-II-F groups and all other mice were euthanized after 14 days of treatment. Herbal components/metabolites were analyzed by UPLC-MS. Tumors were evaluated by weight and volume, morphology of light and electron microscope, and cell cycle. Apoptosis were examined by apoptotic proteins expression by western blot. Four major components/metabolites were identified from serum of mice treated with CHB-II-F and they are β-Sitosterol, Salvianolic acid, isobavachalcone, and bakuchiol. Treatment of CHB-II-F significantly increased body weights of mice and decreased tumor volume compared to untreated group. Moreover, CHB-II-F treatment increased tumor cells in G0-G1 transition instead of in S phase. Furthermore, CHB-II-F treatment increased the expression of pro-apoptotic proteins and decreased the expression anti-apoptotic protein. Therefore, CHB-II-F could improve mice general condition and reduce tumor cell malignancy. Moreover, CHB-II-F regulates apoptosis of tumor cells, which could contribute its protective effect on chemotherapy.https://www.frontiersin.org/article/10.3389/fphar.2018.01539/fullCiji-Hua’ai-Baosheng II FormulachemotherapyH22 hepatocellular carcinomaBcl-2Baxcaspase-3 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Biqian Fu Shengyan Xi Shengyan Xi Shengyan Xi Yanhui Wang Yanhui Wang Yanhui Wang Xiangyang Zhai Yanan Wang Yuewen Gong Yangxinzi Xu Jiaqi Yang Yingkun Qiu Jing Wang Dawei Lu Shuqiong Huang |
spellingShingle |
Biqian Fu Shengyan Xi Shengyan Xi Shengyan Xi Yanhui Wang Yanhui Wang Yanhui Wang Xiangyang Zhai Yanan Wang Yuewen Gong Yangxinzi Xu Jiaqi Yang Yingkun Qiu Jing Wang Dawei Lu Shuqiong Huang The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H22 Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis Frontiers in Pharmacology Ciji-Hua’ai-Baosheng II Formula chemotherapy H22 hepatocellular carcinoma Bcl-2 Bax caspase-3 |
author_facet |
Biqian Fu Shengyan Xi Shengyan Xi Shengyan Xi Yanhui Wang Yanhui Wang Yanhui Wang Xiangyang Zhai Yanan Wang Yuewen Gong Yangxinzi Xu Jiaqi Yang Yingkun Qiu Jing Wang Dawei Lu Shuqiong Huang |
author_sort |
Biqian Fu |
title |
The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H22 Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis |
title_short |
The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H22 Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis |
title_full |
The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H22 Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis |
title_fullStr |
The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H22 Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis |
title_full_unstemmed |
The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H22 Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis |
title_sort |
protective effects of ciji-hua’ai-baosheng ii formula on chemotherapy-treated h22 hepatocellular carcinoma mouse model by promoting tumor apoptosis |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2019-01-01 |
description |
Ciji-Hua’ai-Baosheng II Formula (CHB-II-F) is a traditional Chinese medical formula that has been shown in clinical practice to relieve side effects of chemotherapy and improve quality of life for cancer patients. In order to understand the mechanism of its protective effects on chemotherapy, mice with transplanted H22 hepatocellular carcinoma were employed in this study. Ninety-two mice were injected subcutaneously with H22 HCC cell suspension into the right anterior armpit. After mice were treated with 5-fluorine pyrimidine (5-FU), they were divided into six groups as untreated group, 5-FU group, 5-FU plus Yangzheng Xiaoji Capsule group and three groups of 5-FU plus different concentrations of CHB-II-F. Twenty mice were euthanized after 7 days of treatment in untreated and medium concentration of CHB-II-F groups and all other mice were euthanized after 14 days of treatment. Herbal components/metabolites were analyzed by UPLC-MS. Tumors were evaluated by weight and volume, morphology of light and electron microscope, and cell cycle. Apoptosis were examined by apoptotic proteins expression by western blot. Four major components/metabolites were identified from serum of mice treated with CHB-II-F and they are β-Sitosterol, Salvianolic acid, isobavachalcone, and bakuchiol. Treatment of CHB-II-F significantly increased body weights of mice and decreased tumor volume compared to untreated group. Moreover, CHB-II-F treatment increased tumor cells in G0-G1 transition instead of in S phase. Furthermore, CHB-II-F treatment increased the expression of pro-apoptotic proteins and decreased the expression anti-apoptotic protein. Therefore, CHB-II-F could improve mice general condition and reduce tumor cell malignancy. Moreover, CHB-II-F regulates apoptosis of tumor cells, which could contribute its protective effect on chemotherapy. |
topic |
Ciji-Hua’ai-Baosheng II Formula chemotherapy H22 hepatocellular carcinoma Bcl-2 Bax caspase-3 |
url |
https://www.frontiersin.org/article/10.3389/fphar.2018.01539/full |
work_keys_str_mv |
AT biqianfu theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT shengyanxi theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT shengyanxi theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT shengyanxi theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT yanhuiwang theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT yanhuiwang theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT yanhuiwang theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT xiangyangzhai theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT yananwang theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT yuewengong theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT yangxinzixu theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT jiaqiyang theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT yingkunqiu theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT jingwang theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT daweilu theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT shuqionghuang theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT biqianfu protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT shengyanxi protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT shengyanxi protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT shengyanxi protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT yanhuiwang protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT yanhuiwang protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT yanhuiwang protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT xiangyangzhai protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT yananwang protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT yuewengong protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT yangxinzixu protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT jiaqiyang protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT yingkunqiu protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT jingwang protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT daweilu protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis AT shuqionghuang protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis |
_version_ |
1724775922381357056 |